INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming Deadlines – WGS

Pomerantz Law Firm has filed a class action lawsuit against GeneDx Holdings Corp. alleging securities fraud and unlawful business practices. The lawsuit stems from GeneDx's May 4, 2026 announcement of disappointing Q1 2026 results, including a drop in adjusted gross margin from 74% to 69%, reduced earnings guidance from $540-$555 million to $475-$490 million, and a $31.3 million impairment loss related to its Fabric Genomics acquisition. GeneDx's stock fell 49.20% on the news. The deadline to join the class action is August 3, 2026.